Evrofarma SA - Laporan Laba Rugi (TTM)

Evrofarma SA
GR ˙ ATSE
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Evrofarma SA menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
Revenue 33 34 35 36 36 37 38 39 42 45 47 49 49 49 48 47 46 46
Change (%) 3.38 2.82 2.74 1.23 1.21 2.87 2.79 8.47 7.81 4.26 4.09 -0.49 -0.50 -1.97 -2.01 -1.20 -1.22
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 28 29 30 31 32 33 34 36 37 39 40 41 41 41 41 40 38 36
Change (%) 4.67 2.99 2.91 3.60 3.47 4.04 3.88 5.22 4.60 3.56 2.20 0.21 -0.73 -0.99 -2.36 -4.84 -3.62
% of Revenue 84.25 85.30 85.44 85.58 87.58 89.54 90.55 91.50 88.77 86.13 85.55 84.00 84.59 84.39 85.23 84.92 81.80 79.80
Gross Operating Profit 5 5 5 5 5 4 4 3 5 6 7 8 8 8 7 7 8 9
Change (%) -3.50 1.80 1.76 -12.84 -14.73 -7.06 -7.60 43.43 33.11 8.63 15.26 -4.19 0.80 -7.23 0.04 19.27 9.59
% of Revenue 15.75 14.70 14.56 14.42 12.42 10.46 9.45 8.50 11.23 13.87 14.45 16.00 15.41 15.61 14.77 15.08 18.20 20.20
SG&A 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 6 6
Change (%) -0.09 0.85 0.84 0.00 0.00 2.40 2.35 -2.71 -2.78 1.46 1.44 -1.90 1.47 -2.38 1.00 17.85 12.26
% of Revenue 14.18 13.70 13.44 13.19 13.03 12.88 12.82 12.76 11.45 10.32 10.05 9.79 9.65 9.84 9.80 10.10 12.05 13.70
R&D
Change (%)
% of Revenue
OpEx 31 32 33 34 35 36 38 39 41 43 44 45 45 45 44 43 42 42
Change (%) 3.77 2.79 2.71 3.25 3.15 3.65 3.53 4.67 4.14 3.40 2.22 -0.16 -0.67 -1.00 -1.89 -2.51 -1.65
% of Revenue 95.29 95.65 95.62 95.59 97.51 99.37 100.12 100.83 97.31 94.00 93.22 91.55 91.86 91.70 92.60 92.71 91.48 91.08
Operating Income 2 1 2 2 1 0 -0 -0 1 3 3 4 4 4 4 3 4 4
Change (%) -4.37 3.46 3.34 -42.68 -74.46 -120.13 596.77 -449.85 140.41 17.74 29.69 -4.13 1.45 -12.65 -3.39 15.48 3.46
% of Revenue 4.71 4.35 4.38 4.41 2.49 0.63 -0.12 -0.83 2.69 6.00 6.78 8.45 8.14 8.30 7.40 7.29 8.52 8.92
Interest Expense -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
Change (%) -11.41 -4.66 -4.89 2.77 2.70 -1.09 -1.10 7.21 6.72 8.25 10.90 12.98 17.91 -5.95 -0.53 -1.57 -7.20
% of Revenue -2.80 -2.40 -2.23 -2.06 -2.09 -2.13 -2.04 -1.97 -1.94 -1.92 -2.00 -2.13 -2.42 -2.86 -2.75 -2.79 -2.78 -2.61
Net Income 1 1 1 1 1 -0 -1 -1 0 1 2 3 3 2 2 2 2 2
Change (%) 58.89 15.20 13.20 -62.85 -169.20 96.06 48.99 -118.42 642.93 50.67 33.63 -11.46 -12.95 -0.34 -0.34 2.13 2.08
% of Revenue 2.03 3.12 3.50 3.86 1.41 -0.97 -1.84 -2.67 0.45 3.13 4.52 5.80 5.16 4.52 4.59 4.67 4.83 4.99

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista